The FDA has again approved a generic version of the most commonly prescribed medication for teens in the U.S. without requiring proof that the new product works as well as what kids are currently taking.
FDA takes action on "bad" versions of generic Concerta
The FDA announced plans to rescind the approval of generic versions of Concerta manufactured by Kremers Urban Pharmaceuticals and Mallinckrodt Pharmaceuticals. The drug companies have until mid-November to file a request for a hearing to appeal the decision. Thanks to all of our readers who contacted the FDA to share their experiences with these products.
